Target Organs and Levels of Evidence for TR-585
Toxicology Studies of Green Tea Extract (CASRN GREENTEAEXTR) in F344/NTac Rats and B6C3F1/N Mice and Toxicology and Carcinogenesis Studies of Green Tea Extract in Wistar Han [Crl:WI(Han)] Rats and B6C3F1/N Mice (Gavage Studies)
Chemical CASRN (Study Title) |
Peer Review Date | Primary Uses | Route/Exposure Levels | Study Laboratory |
---|---|---|---|---|
Green tea extract GREENTEAEXTR |
05/22/2014 | Extract of green tea used as dietary supplement | Gavage R: 0, 100, 300, or 1,000 mg/kg; M: 0, 30, 100, or 300 mg/kg; 50/sex/species/dose |
Battelle Columbus Laboratory |
Levels of Evidence
Male Rats: No Evidence
Type | Organ/Tissue (Lesion) |
---|---|
Non-Neoplastic Lesions |
|
Female Rats: No Evidence
Type | Organ/Tissue (Lesion) |
---|---|
Non-Neoplastic Lesions |
|
Male Mice: No Evidence
Type | Organ/Tissue (Lesion) |
---|---|
Non-Neoplastic Lesions |
|
Female Mice: No Evidence
Type | Organ/Tissue (Lesion) |
---|---|
Non-Neoplastic Lesions |
|